Open Access<p>COVID-19 Clinical Trials Registered Worldwide for Drug Intervention: An Overview and Characteristic Analysis</p>
Author(s) -
Bin Wang,
Junkai Lai,
Xiaoyan Yan,
Feifei Jin,
Bin Yi,
Caixia An,
Yuanxiao Li,
Chen Yao
Publication year - 2020
Publication title -
drug design, development and therapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.964
H-Index - 64
ISSN - 1177-8881
DOI - 10.2147/dddt.s281700
Subject(s) - medicine , clinical trial , interquartile range , hydroxychloroquine , randomization , drug , blinding , covid-19 , pharmacology , disease , infectious disease (medical specialty)
This study aims to comprehensively evaluate the characteristics of clinical drug trials to facilitate the collection of evidence for COVID-19 drug treatments.